HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mohan, W. S. Articles by Tam, S.-P. Search for Related Content PubMed PubMed Citation Articles by Mohan, W. S. Articles by Tam, S.-P. Social Bookmarking                      What's this?

The Journal of Lipid Research, Vol. 39, 255-267, February 1998
Copyright © 1998 by Lipid Research, Inc.

Original Article

Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil

Correspondence to: Shui-Pang Tam.

Previously, we demonstrated that protein–DNA interactions at the drug response element (DRE) in the human apoA-I promoter were important for the induction of apoA-I gene expression by gemfibrozil. We now report the cloning and characterization of a DRE transactivating factor. The cloned protein is identical to the putative helicase and potential transcription factor human S mu binding protein-2 (HSµBP2). It is also related to glial factor-1 (GF1), an incomplete version of HSµBP2 lacking the first 494 and the last 128 amino acids. Gel mobility shift assays demonstrated that HSµBP2 binds apoA-I DRE oligomers and forms a specific protein–DNA complex. Northern blot analysis showed that HSµBP2 mRNA is expressed at various levels in a wide range of human tissues. Transient cotransfection experiments performed in HepG2 cells demonstrated that overexpression of HSµBP2 or GF1 induced apoA-I proximal promoter activity by 3-fold and that the apoA-I DRE was necessary for transactivation. Additionally, we demonstrated that transactivation was increased a further 2- to 3-fold by exposing the cells to gemfibrozil.

Together these observations indicate that HSµBP2 acts as a transcription factor that regulates apoA-I gene expression in hepatoma cells and whose activity may be stimulated by gemfibrozil treatment.—Mohan, W. S., Z-Q. Chen, X. Zhang, K. Khalili, T. Honjo, R. G. Deeley, and S-P. Tam. Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil. J. Lipid Res. 1998. 39: 255–267.

Supplementary key words: apolipoprotein A-I, gemfibrozil, gene expression, regulatory sequence, transcription factor

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Grohmann, W. Rossoll, I. Kobsar, B. Holtmann, S. Jablonka, C. Wessig, G. Stoltenburg-Didinger, U. Fischer, C. Hubner, R. Martini, et al. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1) Hum. Mol. Genet., September 15, 2004; 13(18): 2031 - 2042. [Abstract] [Full Text] [PDF]

				X. Zhang, J.-J. Jiao, B. R. Bhavnani, and S.-P. Tam Regulation of human apolipoprotein A-I gene expression by equine estrogens J. Lipid Res., November 1, 2001; 42(11): 1789 - 1800. [Abstract] [Full Text] [PDF]

				W. Hung and B. Elliott Co-operative Effect of c-Src Tyrosine Kinase and Stat3 in Activation of Hepatocyte Growth Factor Expression in Mammary Carcinoma Cells J. Biol. Chem., April 6, 2001; 276(15): 12395 - 12403. [Abstract] [Full Text] [PDF]